申请人:Lipha Lyonnaise Industrielle Pharmaceutique
公开号:US05387709A1
公开(公告)日:1995-02-07
The present invention concerns new substituted sulfonamides, and the physiologically acceptable salts possibly in the form of complexes, esters and amides thereof, represented by the formula: ##STR1##
这项发明涉及新的取代磺胺基化合物,可能以其复合物、酯和酰胺的形式存在的生理上可接受的盐,其化学式如下:##STR1##